YATHARTH

Q4 2025 Result Analysis

delivered a strong performance in Q4FY25 and FY25, driven by a 30% year-on-year increase in Q4 revenue and a 31% rise for the full year. Operational efficiency improved with bed occupancy reaching 61% and ARPOB growing to ₹31,441 in Q4 and ₹30,829 for FY25. Noida Extension and Greater Noida units posted the highest ARPOB growth. EBITDA for FY25 stood at ₹2,202 million, with a margin of 25%, slightly lower than the previous year due to initial costs related to new facilities. PAT increased by 14% for the year, and the company reported strong operating cash flows with a healthy 68% conversion ratio. During the year, the company expanded its infrastructure by acquiring two new hospitals in Delhi and Faridabad, adding around 700 beds, which are expected to become operational in Q1FY26. This positions the company for further growth in FY26. The management highlighted continued focus on super-specialty services, capacity expansion, and investment in advanced medical infrastructure. With ₹5,032 million in net cash and improving performance across all major hospitals, Yatharth is well placed to sustain its growth trajectory and strengthen its position in the healthcare space.